Lecture 10.5 Anti-Hyperlipidemics Flashcards

1
Q
what drug class causes the largest drop in TG's? 
what about LDL?
What drug class increases HDL the most?
A

fibrates;
statins;
niacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

statins (competitively or non-competitively) inhibit ______. they also upregulate _____

A

competitively inhibit HMG CoA reductase;

LDL receptors = reduces plasma chol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

with low cholesterol, the SCAP/SREPB complex is (bound or unbound)? what does it do?

A

unbound; moves to golgi, binds DNA, increases LDL receptor expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

statins are indicated in patients with high _____ or those that have had an _____

A

LDL, acute MI

reduce LDL by 20-60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

short half-life statins should be taken in the _____.

A

evening (to inhibit nocturnal synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

simvastatin and lovastatin should be taken when?

what about rosuvastatin, atorvastatin, and pravastatin?

A

with a meal;

whenever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which statin does not undergo hepatic metabolism ? (ie it undergoes sulfation)

A

pravastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the most common side effect of statins? how do you follow this?

what is another important side effect?

A

rhadomyolysis/myopathy, follow with CPK;

hepatotoxicity (Follow LFTs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

mechanism of action of bile acid resins:

A

prevent intestinal reabsorption of bile acids by forming insoluble complexes with them;
upregulate LDL receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name 3 bile acid resins

A

cholestyamine, colestipol, colesevelam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bile acid resins primary effect on lipoproteins:

A

decrease LDL (by 20%); slightly increase HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

side effects of bile acid resins (2)

A

GI upset, decreased absorption fat soluble vitamins/drugs ie statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what drug inhibits small intestinal absorption of cholesterol? what transporter is specifically inhibited?

A

ezetimibe;

NPC1L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ezetimibe primarily reduces ____;

A

LDL;

rarely causes liver/muscle damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

juxtapid and mipomersen both inhibit _____ synthesis. what disease are they indicated for?

A

Apo B;

homozygous familial hypercholesterolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

alirocumab and evolocumab both inhibit ____.

A

PCSK9 protein

17
Q

what does PCSK9 usually do?

A

promotes degradation of LDL receptors

18
Q

fibrates activate ____ to upregulate ____ and induce ____ synthesis

A

PPAR alpha; Lipoprotein lipase, HDL

19
Q

hit me with 2 fibrates:

A

fenofibrate, gemfibrozil

others exist as well

20
Q

fibrates are especially indicated in patients with ____ in which VLDLs predominate

A

hyper-TG-emia

21
Q

2 side effects of fibrates

A

myopathy (watch with statins);
gall stones

also potentiate effects of warfarin

22
Q

what dietary supplement can reduce TG synthesis?

A

omega 3 FA (Fish oil/lovaza)

23
Q

niacin is thought to increase ____ activity and decrease _____ production. niacin ____ hormone synthesis lipase in adipose tissue

A

lipase (increases VLDL clearance);
VLDL (in liver);
inhibits

24
Q

in MQs, niacin increases expression of CD36 and ____, causing increased Reverse cholesterol transport

A

ABCA1

25
Q

most common side effect of niacin:

how to help treat this?

A
cutaneous vasodilation, warmth;
use NSAIDs (inhibits PG release)
26
Q

3 other side effects of niacin:

A

hyperglycemia, hyperuricemia, hepatotoxicity